NCT00003396 Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00003361 Decitabine in Treating Patients With Myelodysplastic Syndrome Status COMPLETED Phase PHASE2
NCT00003336 Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions Status COMPLETED Phase PHASE2
NCT00003335 Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00003331 Combination Chemotherapy in Treating Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT00003270 Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00003243 Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE1
NCT00003187 Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma Status COMPLETED Phase PHASE2/PHASE3
NCT00003171 Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome Status COMPLETED Phase PHASE2
NCT00003138 Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes Status COMPLETED Phase PHASE3
NCT00003123 Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome Status UNKNOWN Phase PHASE2
NCT00003116 High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00003107 Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors Status COMPLETED Phase PHASE1
NCT00003082 Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT00003048 Amifostine in Treating Patients With Myelodysplastic Syndrome Status COMPLETED Phase PHASE2
NCT00002989 Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Status UNKNOWN Phase PHASE3
NCT00002980 Decitabine in Treating Patients With Melanoma or Other Advanced Cancer Status COMPLETED Phase PHASE1
NCT00002926 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia Status UNKNOWN Phase PHASE3
NCT00002890 Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia Status COMPLETED Phase PHASE1
NCT00002833 Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia Status COMPLETED Phase PHASE2